Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392

Watchlist Manager
Beijing Wantai Biological Pharmacy Enterprise Co Ltd Logo
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Watchlist
Price: 65 CNY -0.28% Market Closed
Market Cap: 82.2B CNY

Intrinsic Value

The intrinsic value of one Beijing Wantai Biological Pharmacy Enterprise Co Ltd stock under the Base Case scenario is 63.13 CNY. Compared to the current market price of 65 CNY, Beijing Wantai Biological Pharmacy Enterprise Co Ltd is Overvalued by 3%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
63.13 CNY
Overvaluation 3%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Beijing Wantai Biological Pharmacy Enterprise Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for Beijing Wantai Biological Pharmacy Enterprise Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
CN
Biotechnology
Market Cap
82.2B CNY
IPO
Apr 29, 2020
CN
Biotechnology
Market Cap
82.2B CNY
IPO
Apr 29, 2020
Price
ÂĄfalse
EPS
ÂĄfalse
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
Company Overview
Loading...
Business Segments
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Beijing Wantai Biological Pharmacy Enterprise Co Ltd?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Beijing Wantai Biological Pharmacy Enterprise Co Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Beijing Wantai Biological Pharmacy Enterprise Co Ltd

Current Assets 9B
Cash & Short-Term Investments 4.9B
Receivables 2.5B
Other Current Assets 1.6B
Non-Current Assets 5.8B
Long-Term Investments 1.1B
PP&E 3.3B
Intangibles 685.7m
Other Non-Current Assets 669.6m
Efficiency

Free Cash Flow Analysis
Beijing Wantai Biological Pharmacy Enterprise Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Beijing Wantai Biological Pharmacy Enterprise Co Ltd

Revenue
2.5B CNY
Cost of Revenue
-771.7m CNY
Gross Profit
1.7B CNY
Operating Expenses
-2.3B CNY
Operating Income
-544.9m CNY
Other Expenses
250.8m CNY
Net Income
-294m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Beijing Wantai Biological Pharmacy Enterprise Co Ltd's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Exceptional 3-Year Average ROE
Positive Gross Profit
Negative Free Cash Flow
59/100
Profitability
Score

Beijing Wantai Biological Pharmacy Enterprise Co Ltd's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Beijing Wantai Biological Pharmacy Enterprise Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
87/100
Solvency
Score

Beijing Wantai Biological Pharmacy Enterprise Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Beijing Wantai Biological Pharmacy Enterprise Co Ltd

Wall Street analysts forecast Beijing Wantai Biological Pharmacy Enterprise Co Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Beijing Wantai Biological Pharmacy Enterprise Co Ltd is 62.63 CNY with a low forecast of 48.99 CNY and a high forecast of 78.02 CNY.

Lowest
Price Target
48.99 CNY
25% Downside
Average
Price Target
62.63 CNY
4% Downside
Highest
Price Target
78.02 CNY
20% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Beijing Wantai Biological Pharmacy Enterprise Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one Beijing Wantai Biological Pharmacy Enterprise Co Ltd stock?

The intrinsic value of one Beijing Wantai Biological Pharmacy Enterprise Co Ltd stock under the Base Case scenario is 63.13 CNY.

Is Beijing Wantai Biological Pharmacy Enterprise Co Ltd stock undervalued or overvalued?

Compared to the current market price of 65 CNY, Beijing Wantai Biological Pharmacy Enterprise Co Ltd is Overvalued by 3%.

Back to Top